A phase I/II trial of dapagliflozin in 38 lupus patients (including with and without lupus nephritis) showed an acceptable safety profile, with no increase in disease activity or proteinuria over the 6 months of the study
Mueller AA, van Velthoven CT, Fukumoto K, Cheung TH, Rando TA (2016) Intronic polyadenylation of PDGFR in resident stem cells attenuates muscle fibrosis
Your provider will work with you to find the minimum effective dose that keeps you feeling satisfied and prevents creeping weight regain
Speak to your healthcare provider before making any of these changes
[5] The severity of SCD is generally less when compared to PCD as the plasma carnitine levels are relatively higher and hence easier to manage.[3][8]Patients with SCD, in general, do not have hepatic or cardiac involvement
Your doctor will manage this switch based on your current blood sugar control, side effects, and overall health